A new hope: Clinical advances in targeted therapies for pediatric diffuse midline glioma
Summary
Diffuse midline glioma (DMG) is an aggressive pediatric brain tumor with a 1%-2% overall survival, largely due to the ineffectiveness of conventional treatments...
Description
Diffuse midline glioma (DMG) is an aggressive pediatric brain tumor with a 1%-2% overall survival, largely due to the ineffectiveness of conventional treatments...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source